Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]ZYME$28.22-0.22(-0.77%)Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026[2:30:00 AM ET]IMTX$7.31-0.23(-3.05%)Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting[2:30:00 AM ET]LLY$1,279.00-27.69(-2.12%)Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026 Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its investigational folate receptor alpha (FRα) antibody-drug...[2:30:00 AM ET]

MP · NYSE

MP Materials Corp.

$38.50 -0.26 (-0.67%)

Company overview

MP Materials Corp. owns and operates rare earth mining and processing facilities. The company owns and operates the Mountain Pass Rare Earth mine, which is located in the Western Hemisphere. MP Materials holds the mineral rights to the Mountain Pass mine and surrounding areas, as well as intellectual property rights related to the processing and development of rare earth minerals. Its product offerings include cerium, lanthanum, neodymium, praseodymium, and samarium. The company was founded in 2017 and is headquartered in Las Vegas, Nevada.

Sector
Basic Materials
Industry
Industrial Materials
Exchange
NYSE
Market cap
$6.9B
Employees
804
Headquarters
Las Vegas, NV
Website
mpmaterials.com
CEO
James Henry Litinsky
Listed
June 22, 2020
P/E
-91.28
Dividend yield
0.00%

Company financials

Revenue
$348M
Gross profit
$84M
Operating income
-$137M
EBITDA
$18.8M
Net income
-$71.2M
EPS
-$0.42
Total assets
$3.8B
Total debt
$1B
Gross margin
24.16%
Net margin
-20.48%
Earnings yield
-1.10%

Revenue segmentation

By product (FY 2024)
By region (FY 2024)

No geographic segmentation.

Showing FY 2024

Price chart

35.5246.2456.9667.6778.39
MP 1D NYSE O38.14H38.87L37.11C38.30-0.26 (-0.67%)Vol1.26M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
MP Stock news Is MP Materials Stock a Millionaire Maker? The Motley Fool
MP Stock news MP vs. LYSDY: Which Rare Earth Stock Has an Edge Right Now? Zacks Investment Research
MP Stock news Could Investing $10,000 in USA Rare Earth Make You a Millionaire? The Motley Fool
MP Stock news Is MP Materials Stock Still a Buy After Its Recent Pullback? The Motley Fool
MP Press release The Race for Critical Minerals Is Heating Up — Antimony and Gold Could Be Major Beneficiaries GlobeNewswire
GAMI Press release Gabelli Releases Agenda for 50th Annual Automotive Symposium GlobeNewswire
MP Stock news MP Materials vs. USA Rare Earth: Which Rare Earth Stock Is the Better Buy? The Motley Fool
MP Stock news USA Rare Earth Climbs 4% as Month-Long Selloff Pauses; MP Materials Ticks Up, United States Antimony Dips 24/7 Wall Street
MP Stock news Rare Earths Stock Extends Slide, Eyes 52-Week Low Schaeffers Research
MP Stock news Critical Metals Rises 4% on Trump’s Greenland Mineral Exploration Plan; USA Rare Earth Declines 3%, MP Materials Slips 2% 247 Wallst
MP Stock news Can MP Materials Sustain the Growth Momentum in Its Materials Segment? Zacks Investment Research
MP Stock news USA Rare Earth Drops 6% With Milestone-Based Government Funding Still Ahead of It; MP Materials Falls 6%, Critical Metals Holds Steady 24/7 Wall Street
MP Stock news China Still Dominates Rare Earths—These 3 U.S. Companies Could Benefit MarketBeat
MP Stock news What $10,000 Invested in USA Rare Earth 1 Year Ago Is Worth Today The Motley Fool
MP Stock news USA Rare Earth Drops 5% as Selling Runs Into a Second Day; United States Antimony Falls 4%, MP Materials Dips 24/7 Wall Street
MP Stock news Can MP Materials Deliver Another Year of Production Growth? Zacks Investment Research
MP Stock news Is MP Stock a Buy, Hold or Sell After Its 31.2% One-Year Decline? Zacks Investment Research
MP Stock news USA Rare Earth and MP Materials Fall 5% as Rare Earth Stocks Slide Together; Critical Metals Declines 3% 24/7 Wall Street
MP Stock news MP Materials Corp (MP) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 74/100 GuruFocus
MP Stock news First Citizens BancShares vs MP Materials: A Tale of 2 Regulation Bets MarketBeat
See more
FAQ

Questions about MP Materials Corp.

What does MP Materials Corp. do?
MP Materials Corp. owns and operates rare earth mining and processing facilities. The company owns and operates the Mountain Pass Rare Earth mine, which is located in the Western Hemisphere. MP Materials holds the mineral rights to the Mountain Pass mine and surrounding areas, as well as intellectual property rights related to the processing and development of rare earth minerals. Its product offerings include cerium, lanthanum, neodymium, praseodymium, and samarium. The company was founded in 2017 and is headquartered in Las Vegas, Nevada.
What is MP's market cap?
MP Materials Corp. (MP) is a listed stock with a live quote. The latest market cap on this page is $6.9B.
Where is MP Materials Corp. headquartered?
MP Materials Corp. is headquartered in Las Vegas, NV.
How do I get MP news from the API?
Call GET /v1/news?tickers=MP. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does MP news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for MP, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the MP price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs